Skip to main content
Erschienen in: International Journal of Hematology 3/2009

01.10.2009 | Original Article

Suppressed neutrophil function in children with acute lymphoblastic leukemia

verfasst von: Fumiko Tanaka, Hiroaki Goto, Tomoko Yokosuka, Masakatsu Yanagimachi, Ryosuke Kajiwara, Takuya Naruto, Shigeru Nishimaki, Shumpei Yokota

Erschienen in: International Journal of Hematology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

Infection is a major obstacle in cancer chemotherapy. Neutropenia has been considered to be the most important risk factor for severe infection; however, other factors, such as impaired neutrophil function, may be involved in susceptibility to infection in patients undergoing chemotherapy. In this study, we analyzed neutrophil function in children with acute lymphoblastic leukemia (ALL). Whole blood samples were obtained from 16 children with ALL at diagnosis, after induction chemotherapy, and after consolidation chemotherapy. Oxidative burst and phagocytic activity of neutrophils were analyzed by flow cytometry. Oxidative burst of neutrophils was impaired in ALL patients. The percentage of neutrophils with normal oxidative burst after PMA stimulation was 59.0 ± 13.2 or 70.0 ± 21.0% at diagnosis or after induction chemotherapy, respectively, which was significantly lower compared with 93.8 ± 6.1% in healthy control subjects (P = 0.00004, or 0.002, respectively); however, this value was normal after consolidation chemotherapy. No significant differences were noted in phagocytic activity in children with ALL compared with healthy control subjects. Impaired oxidative burst of neutrophils may be one risk factor for infections in children with ALL, especially in the initial periods of treatment.
Literatur
1.
Zurück zum Zitat Christensen MS, Heyman M, Mottonen M, Zeller B, Jonmundsson G, Hasle H. Nordic Society of Paediatric Haematology and Oncology (NOPHO): treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001. Br J Haematol. 2005;131:50–8.CrossRefPubMed Christensen MS, Heyman M, Mottonen M, Zeller B, Jonmundsson G, Hasle H. Nordic Society of Paediatric Haematology and Oncology (NOPHO): treatment-related death in childhood acute lymphoblastic leukaemia in the Nordic countries: 1992–2001. Br J Haematol. 2005;131:50–8.CrossRefPubMed
2.
Zurück zum Zitat Rubnitz JE, Lensing S, Zhou Y, Sandlund JT, Razzouk BI, Ribeiro RC, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer. 2004;101:1677–84.CrossRefPubMed Rubnitz JE, Lensing S, Zhou Y, Sandlund JT, Razzouk BI, Ribeiro RC, et al. Death during induction therapy and first remission of acute leukemia in childhood: the St. Jude experience. Cancer. 2004;101:1677–84.CrossRefPubMed
3.
Zurück zum Zitat Hargrave DR, Hann II, Richards SM, Hill FG, Lilleyman JS, Kinsey S, et al. Medical Research Council Working Party for Childhood Leukaemia: progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol. 2001;112:293–9.CrossRefPubMed Hargrave DR, Hann II, Richards SM, Hill FG, Lilleyman JS, Kinsey S, et al. Medical Research Council Working Party for Childhood Leukaemia: progressive reduction in treatment-related deaths in Medical Research Council childhood lymphoblastic leukaemia trials from 1980 to 1997 (UKALL VIII, X and XI). Br J Haematol. 2001;112:293–9.CrossRefPubMed
4.
Zurück zum Zitat Offidani M, Corvatta L, Malerba L, Marconi M, Leoni P. Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center. Leuk Lymphoma. 2004;45:1617–21.CrossRefPubMed Offidani M, Corvatta L, Malerba L, Marconi M, Leoni P. Infectious complications in adult acute lymphoblastic leukemia (ALL): experience at one single center. Leuk Lymphoma. 2004;45:1617–21.CrossRefPubMed
5.
Zurück zum Zitat Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G, et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood. 2002;99:863–71.CrossRefPubMed Annino L, Vegna ML, Camera A, Specchia G, Visani G, Fioritoni G, et al. Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study. Blood. 2002;99:863–71.CrossRefPubMed
6.
Zurück zum Zitat Bodey GP. Infection in cancer patients: a continuing association. Am J Med. 1986;81:11–26. Review.CrossRefPubMed Bodey GP. Infection in cancer patients: a continuing association. Am J Med. 1986;81:11–26. Review.CrossRefPubMed
7.
Zurück zum Zitat Yamamoto K, Sasada M, Nishiyama H, Uchida M, Sawada H, Nakamura T, et al. Ingestion and killing of bacteria by neutrophils from patients with leukemia: a new method for evaluating phagocyte function at short incubation. Acta Haematol Jpn. 1982;45:56–65. Yamamoto K, Sasada M, Nishiyama H, Uchida M, Sawada H, Nakamura T, et al. Ingestion and killing of bacteria by neutrophils from patients with leukemia: a new method for evaluating phagocyte function at short incubation. Acta Haematol Jpn. 1982;45:56–65.
8.
Zurück zum Zitat Hubel K, Hegener K, Schnell R, Mansmann G, Oberhauser F, Staib P, et al. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann Hematol. 1999;78:73–7.CrossRefPubMed Hubel K, Hegener K, Schnell R, Mansmann G, Oberhauser F, Staib P, et al. Suppressed neutrophil function as a risk factor for severe infection after cytotoxic chemotherapy in patients with acute nonlymphocytic leukemia. Ann Hematol. 1999;78:73–7.CrossRefPubMed
9.
Zurück zum Zitat Hofmann WK, Stauch M, Hoffken K. Impaired granulocytic function in patients with acute leukaemia: only partial normalisation after successful remission-inducing treatment. J Cancer Res Clin Oncol. 1998;124:113–6.CrossRefPubMed Hofmann WK, Stauch M, Hoffken K. Impaired granulocytic function in patients with acute leukaemia: only partial normalisation after successful remission-inducing treatment. J Cancer Res Clin Oncol. 1998;124:113–6.CrossRefPubMed
10.
Zurück zum Zitat Lejeune M, Ferster A, Cantinieaux B, Sariban E. Prolonged but reversible neutrophil dysfunctions differentially sensitive to G-CSF in children with ALL. Br J Haematol. 1998;102:1284–91.CrossRefPubMed Lejeune M, Ferster A, Cantinieaux B, Sariban E. Prolonged but reversible neutrophil dysfunctions differentially sensitive to G-CSF in children with ALL. Br J Haematol. 1998;102:1284–91.CrossRefPubMed
11.
Zurück zum Zitat Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group Study L99-15. Haematologica. 2008;93:1155–60.CrossRefPubMed Manabe A, Ohara A, Hasegawa D, Koh K, Saito T, Kiyokawa N. Significance of the complete clearance of peripheral blasts after 7 days of prednisolone treatment in children with acute lymphoblastic leukemia: the Tokyo Children’s Cancer Study Group Study L99-15. Haematologica. 2008;93:1155–60.CrossRefPubMed
12.
Zurück zum Zitat Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910–7.PubMed Bass DA, Parce JW, Dechatelet LR, Szejda P, Seeds MC, Thomas M. Flow cytometric studies of oxidative product formation by neutrophils: a graded response to membrane stimulation. J Immunol. 1983;130:1910–7.PubMed
13.
Zurück zum Zitat Walrand S, Valeix S, Rodriguez C, Ligot P, Chassagne J, Vasson MP. Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes. Clin Chim Acta. 2003;331:103–10.CrossRefPubMed Walrand S, Valeix S, Rodriguez C, Ligot P, Chassagne J, Vasson MP. Flow cytometry study of polymorphonuclear neutrophil oxidative burst: a comparison of three fluorescent probes. Clin Chim Acta. 2003;331:103–10.CrossRefPubMed
14.
Zurück zum Zitat Dunn PA, Tyrer HW. Quantitation of neutrophil phagocytosis, using fluorescent latex beads: correlation of microscopy and flow cytometry. J Lab Clin Med. 1981;98:374–81.PubMed Dunn PA, Tyrer HW. Quantitation of neutrophil phagocytosis, using fluorescent latex beads: correlation of microscopy and flow cytometry. J Lab Clin Med. 1981;98:374–81.PubMed
15.
Zurück zum Zitat Katsimpardi K, Papadakis V, Pangalis A, Parcharidou A, Panagiotou JP, Soutis M, et al. Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment. Support Care Cancer. 2006;14:277–84.CrossRefPubMed Katsimpardi K, Papadakis V, Pangalis A, Parcharidou A, Panagiotou JP, Soutis M, et al. Infections in a pediatric patient cohort with acute lymphoblastic leukemia during the entire course of treatment. Support Care Cancer. 2006;14:277–84.CrossRefPubMed
16.
Zurück zum Zitat Tsurumi H, Shimazaki M, Takahashi T, Moriwaki H, Muto Y. Flow cytometric determination of active oxygen (hydroperoxide) produced by peripheral blood neutrophils in patients with hematological disorders. Int J Hematol. 1993;57:213–9.PubMed Tsurumi H, Shimazaki M, Takahashi T, Moriwaki H, Muto Y. Flow cytometric determination of active oxygen (hydroperoxide) produced by peripheral blood neutrophils in patients with hematological disorders. Int J Hematol. 1993;57:213–9.PubMed
17.
Zurück zum Zitat Lewkowicz P, Lewkowicz N, Sasiak A, Tchorzewski H. Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol. 2006;177:7155–63.CrossRefPubMed Lewkowicz P, Lewkowicz N, Sasiak A, Tchorzewski H. Lipopolysaccharide-activated CD4+CD25+ T regulatory cells inhibit neutrophil function and promote their apoptosis and death. J Immunol. 2006;177:7155–63.CrossRefPubMed
18.
Zurück zum Zitat Wu S, Gessner R, von Stackelberg A, Kirchner R, Henze G, Seeger K. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence. Cancer. 2005;103:1054–63.CrossRefPubMed Wu S, Gessner R, von Stackelberg A, Kirchner R, Henze G, Seeger K. Cytokine/cytokine receptor gene expression in childhood acute lymphoblastic leukemia: correlation of expression and clinical outcome at first disease recurrence. Cancer. 2005;103:1054–63.CrossRefPubMed
19.
Zurück zum Zitat Kuga S, Otsuka T, Niiro H, Nunoi H, Nemoto Y, Nakano T, et al. Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp Hematol. 1996;24:151–7.PubMed Kuga S, Otsuka T, Niiro H, Nunoi H, Nemoto Y, Nakano T, et al. Suppression of superoxide anion production by interleukin-10 is accompanied by a downregulation of the genes for subunit proteins of NADPH oxidase. Exp Hematol. 1996;24:151–7.PubMed
Metadaten
Titel
Suppressed neutrophil function in children with acute lymphoblastic leukemia
verfasst von
Fumiko Tanaka
Hiroaki Goto
Tomoko Yokosuka
Masakatsu Yanagimachi
Ryosuke Kajiwara
Takuya Naruto
Shigeru Nishimaki
Shumpei Yokota
Publikationsdatum
01.10.2009
Verlag
Springer Japan
Erschienen in
International Journal of Hematology / Ausgabe 3/2009
Print ISSN: 0925-5710
Elektronische ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-009-0412-4

Weitere Artikel der Ausgabe 3/2009

International Journal of Hematology 3/2009 Zur Ausgabe

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

CUP-Syndrom: Künstliche Intelligenz kann Primärtumor finden

30.04.2024 Künstliche Intelligenz Nachrichten

Krebserkrankungen unbekannten Ursprungs (CUP) sind eine diagnostische Herausforderung. KI-Systeme können Pathologen dabei unterstützen, zytologische Bilder zu interpretieren, um den Primärtumor zu lokalisieren.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.